Dean J. Burkin
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$2.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 16, 2021 | NIH | STTR Phase II Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy | $752K | STRYKAGEN CORPORATION |
| Aug 25, 2020 | NIH | STTR Phase II Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy | $748K | STRYKAGEN CORPORATION |
| Jun 22, 2018 | NIH | STTR Phase I Galectin-1 Protein Therapy for Congenital Muscular Dystrophy | $225K | STRYKAGEN CORPORATION |
| Jul 7, 2015 | NIH | STTR Phase I Galectin 1: A novel small protein therapy for Duchenne muscular dystrophy | $5K | STRYKAGEN CORPORATION |
| Mar 18, 2015 | NIH | STTR Phase I Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy | $225K | STRYKAGEN CORPORATION |
Peer ranks
Federal funding#1,083
Awards as PI#417
Patents#273
Companies
- STRYKAGEN CORPORATIONLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.